Fahey Sandell Jacquelyn has filed 8 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 41500 shares of Voyager Therapeutics, Inc. ($VYGR) on February 21, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Common Stock | 41500 | $0.00 | 123,143.0000 | 57,667,543 | 50.83% | 0.07% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Stock Option (Right to Buy) | 83000 | $0.00 | 83,000.0000 | 57,667,543 | 9999.99% | 0.14% |
| Feb. 11, 2025 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | S | Common Stock | 4358 | $4.45 | 81,643.0000 | 57,667,543 | 5.07% | 0.01% |
| Oct. 2, 2024 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | S | Common Stock | 5999 | $5.82 | 86,001.0000 | 57,851,110 | 6.52% | 0.01% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Common Stock | 31000 | $0.00 | 92,000.0000 | 44,569,334 | 50.82% | 0.07% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Stock Option (Right to Buy) | 62000 | $0.00 | 62,000.0000 | 44,569,334 | 9999.99% | 0.14% |
| Oct. 1, 2023 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Common Stock | 61000 | $0.00 | 61,000.0000 | 43,864,838 | 9999.99% | 0.14% |
| July 10, 2023 | Voyager Therapeutics, Inc. | $VYGR | Fahey Sandell Jacquelyn | Chief Legal Officer | A | Stock Option (Right to Buy) | 122000 | $0.00 | 122,000.0000 | 43,520,137 | 9999.99% | 0.28% |